Cellectis Announces Completion of the Additional Equity Inve

Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 -- Cellectis a clinical-stage biotechnology...

Related Keywords

Paris , France General , France , North Carolina , United States , New York , Raleigh , French , Patricia Sosa Navarro , Pascalyne Wilson , Arthur Stril , Ashleyr Robinson , Marc Dunoyer , Astrazeneca , Nasdaq , French Ministry Of Economy , Euronext Growth , French Ministry , Additional Investment , Tyrell Rivers , Nasdaq Global Market , Sosa Navarro , Chief Business Officer , Lifesci Advisors , Markets ,